Worldwide, photochemotherapy (PCT) is being evaluated as a new modality of cancer treatment (Henderson and Dougherty, 1992; Moan and Berg, 1992) . It is based on injection of photosensitising and tumour localising dyes followed by exposure of the tumour region to high fluences of light, usually from a laser. A variety of different types of tumours respond to PCT.
The fact that certain porphyrins administered to tumourbearing animals tend to accumulate in tumour tissue has been known for more than 50 years (Policard, 1924) . Since most porphyrins exhibit a characteristic red fluorescence, their tumour-localising properties can be used for tumour detection (Lipson et al., 1967; Pope et al., 1991) . The photosensitising properties of porphyrins, together with their tumour-localising properties, were first exploited for therapeutic purposes by Auler and Banzer (1943) . The first cancer patients were treated with porphyrin-based PCT in 1976 (Kelly and Snell, 1976) , and today more than 10 000 patients have been treated with PCT.
A somewhat different approach to PCT is based on the endogenous synthesis of porphyrins (Malik and Lugaci, 1987; Kennedy and Pottier, 1992) . The initial step in the porphyrin synthesis pathway is the 5-aminolaevulinic acid (ALA) synthase-induced formation of 5-aminolaevulinic acid from succinyl-CoA and glycine. This pathway, ultimately leading to the formation of haem, is regulated by the feedback inhibition of ALA synthase activity by haem (Kennedy et al., 1990) . The feedback regulation is overruled by treating cells with 5-ALA. Several porphyrinogens are formed by the pathway, from which photoactive porphyrins can be formed by auto-oxidation. Fortunately for the treatment of cancer, the ferrochelatase (protohaem ferrolyase, EC 4.99.1.1) activity needed for the incorporation of iron into the protoporphyrin IX macrocycle, is low in neoplastic cells (Dailey and Smith, 1984; van Hillegersberg et al., 1992; Schoenfeld et al., 1988; el-Sharabasy et al., 1992) . Oseroff and coworkers hypothesise that malignant cells that have an increased expression of transferrin receptors will also have low levels of intracellular iron (Rittenhouse-Diakun et al., 1995) . Furthermore, fast-growing neoplastic cells usually have an elevated capability for synthesising porphyrins compared with their normal counterparts. Thus, ALA has been used with great success for the treatment of several neoplastic diseases. A large clinical experience already exists on the treatment of basal and squamous cell carcinoma of the skin. The results obtained show very good clinical responses and cosmetic outcome of the treatment (Heyerdahl et al., 1993) . However, the PCT effects on lesions thicker than > 1 mm need to be improved.
A crucial point for the success of ALA-PCT is a low ferrochelatase activity in the tumour. However, all porphyrinproducing cells contain some ferrochelatase activity. Inhibition of the ferrochelatase activity by chelators of iron has been found to enhance the accumulation of PpIX as well as the sensitivity of cells to ALA-induced photosensitisation (Hanania and Malik, 1992; Ortel et al., 1993) . The two most commonly used chelators for this purpose are ethylenediaminetetraacetic acid (EDTA), an unspecific membraneimpermeable chelator, and desferrioxamine (DEF), which is specific for iron and can penetrate into the cellular cytosol. The ratio between the ALA-induced formation of PpIX and the cellular capability of incorporating iron into the PpIX macrocycle may be dependent on the cell line and on the ALA concentration. So far, no studies have been performed to compare the efficacy of these chelators in enhancing the PpIX accumulation in the same cell lines. In the present study EDTA and DEF were compared for their effects in enhancing ALA-induced PpIX accumulation and photosensitisation in two cell lines of different origin and with different growth rates. The maximal effect of DEF on PpIX accumulation in 5-ALA-treated cells was also estimated. Additionally, 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), a methylated dihydropyridine, which N-alkylates porphyrins and thereby inhibits the ferrochelatase, was also investigated for its potentially modulating effect on PpIX accumulation.
Materials and methods
Cell cultivation Cells of the established line WiDr (doubling time ,30 h), derived from a primary adenocarcinoma of the rectosigmoid colon (Noguchi et al., 1979) , and V79 cells (doubling time % 10 h), derived from Chinese hamster lung fibroblasts, were used. Both cell lines were grown in RPMI-1640 medium containing 10% fetal calf serum (FCS), 100 U ml-' penicillin and 100 ig ml-' streptomycin at 37°C in an incubator flushed with 5% carbon dioxide in air. The cells were subcultured twice a week (split ratio 1 :100). tion applied (Figure 3c ). In V79 cells both EDTA and DEF significantly increased the accumulation of PpIX at all selected concentrations of 5-ALA (Figure 4 ). In particular, treatment with 1 mM DEF was highly efficient, and the accumulation of PpIX was enhanced 2.4-fold even at 0.1 mM 5-ALA. As in the case of WiDr cells, the relative chelator-induced increase in PpIX accumulation was inversely related to the applied concentration of 5-ALA ( Figure 5 ). In V79 cells treated with 0.025 mM 5-ALA a more than 30-fold increase in PpIX accumulation was often observed by cotreatment with 1 mM DEF. To reveal the optimal 5-ALA concentration for DEF-induced enhancement of PpIX accumulation, the 5-ALA concentration was varied in the range 0-0.05 mM in the absence or presence of 1 mM DEF (Figure 6 ). DEF increased the PpIX accumulation in the whole range studied with a maximum enhancement at 0.020 mM 5-ALA. At the lowest concentrations of 5-ALA applied, the absolute relative increase varied between separate experiments as a result of a very low and two highest concentrations of exogenously applied 5-ALA. These data indicate that these 5-ALA concentrations saturate the ferrochelatase with its substrate PpIX, and Vmax from these 5-ALA concentrations therefore reflect the maximal rate of iron insertion into PpIX in these cell lines under the present conditions. The AVmax after treatment with the lowest concentration of 5-ALA was substantially lower in both cell lines, indicating that at these concentrations 5-ALA induced formation of suboptimal concentrations of PpIX as a substrate for ferrochelatase. The 5-ALA-induced formation of PpIX and the maximum obtainable enhancement inducible by DEF is illustrated in Figure 9 . 
Analysis of accumulated porphyrin intermediates
The fluorescence emission spectrum of PpIX is slightly redshifted compared with the two other main intermediates in the porphyrin synthesis pathway, uro-and coproporphyrin (Granick et al., 1975 ALA treatment induce accumulation of other porphyrin intermediates than does 5-ALA alone. (Figure 11 ). Retention time (min) Figure 10 HPLC analysis of porphyrin extracts from V79 cells treated with 5-ALA alone or in combination with the compounds described on the figure. The cells were treated for 4h in serumfree medium and porphyrins extracted from the cells as described in Materials and methods. Standards for uroporphyrin (URO), coproporphyrin (COPRO) and PpIX are included.
was performed on the cells. Only DEF induced a substantial inhibition of the colony-forming ability of the cells and only at concentrations higher than 0.1 mM (data not shown). EDTA was found to reduce the number of colonies in some cases. This was assumed to be due to the effect of EDTA on the binding of cells to the substratum.
The cytotoxic effect of DEF prohibited comparative studies of the combination of 5-ALA-PCT and optimal concentrations of iron chelators. Therefore, suboptimal concentrations (100 uM) of the modulators have been combined with 5-ALA-PCT in a colony-forming assay. The sensitivity of the cells to photoinactivation was substantially enhanced by the iron chelators only at the low concentration of 5-ALA (Figure 12 ). Also in accordance with the results on PpIX accumulation, DEF sensitised the cells to photoinactivation to a higher extent than EDTA. DDC did not significantly change the sensitivity of the cells to ALA-PCT despite a reduced formation of PpIX in the presence of DDC.
Discussion
The purpose of the current studies has been to elucidate further the influence of iron chelators on the rate of PpIX accumulation. This has been performed by studying the effect of the iron chelators, EDTA and DEF, at different concentrations of chelators and 5-ALA. Both chelators have previously been applied to cells in vitro and shown to increase the accumulation of PpIX and the sensitivity of the cells to photoinactivation in the presence of 5-ALA (Hanania and Malik, 1992; Ortel et al., 1993) . However, a complete study to reveal the maximal possible gain in using iron chelators at different concentrations of 5-ALA has not previously been performed. The two iron chelators compared in this study have different physicochemical properties. EDTA is a membrane-impermeable chelator (Richardson et al., 1994) with affinity for several cations, of which that for Fe3" is notably high (logK,. %25) compared with that for, for example, Ca2" (logKm 10.7; Keberle, 1964) . EDTA has been used clinically in a cream together with 5-ALA and dimethyl sulphoxide (DMSO) for topical application (Heyerdahl et at., 1993; Orenstein et al., 1994) . The sideramine DEF, on the other hand, is a highly specific membrane-permeable iron chelator with very high affinity for iron (logK=31; Keberle, 1964) . DEF has so far not been used in clinical 5-ALA-PCT, but is promising as an anti- Figure 11 Fluorescence micrographs of V79 cells treated with 0.1 mm 5-ALA alone or in combination with iron chelators as indicated on the figure. The cells were treated for 4 h in serum-free medium as described in Materials and methods. neoplastic agent alone and is currently used clinically to treat iron overload diseases such as thalassemia and transfusionrelated overload (Blatt, 1994; Richardson et al., 1994) . In the present study both chelators were found to increase the accumulation of PpIX in 5-ALA-treated cells, although DEF was more efficient on a molar basis (Figures 3 and 5) . This is most likely because of the intracellular localisation of DEF, the slow release of iron from cells (Richardson et al., 1994) and EDTA's binding to other cations. DEF supposedly binds iron from the intracellular iron pool which most likely consists of small molecular weight iron chelates of sugars, amino acids and nucleotides, all with low affinity for iron (Jacobs, 1977) in addition to ferritin. In this way DEF may reduce the amount of iron accessible for the ferrochelatase. On the basis of the present results, it may be advantagous to use DEF instead of EDTA as enhancer of PpIX accumulation. Our recent results also indicate that the gain in using DEF is significantly higher than that in using EDTA in combination with 5-ALA for the formation of fluorescing porphyrins in mouse skin (Peng et al., 1996) .
The iron chelator-induced increase in PpIX accumulation (AV) was found to be saturable (Figure 7 ). The linear relationship between AV`1 and [DEF]-' indicates that the rate of iron incorporation into PpIX in cells follows Michaelis-Menten kinetics. This is in accordance with data on purified ferrochelatase (Taketani and Tokunaga, 1982; Ferreira, 1994) . In both V79 and WiDr cells the accumulation of PpIX is increased from the medium to the highest concentrations of 5-ALA (Figure 1 ), whereas the doublereciprocal curves for DEF-induced increase in PpIX accumulation (Figure 8) and Tokunaga, 1982; Ferreira, 1994) . However, PpIX is clearly not homogeneously distributed intracellularly but highly concentrated in mitochondria (linuma et al., 1994) , lysosomes (Gaullier et al., 1995) and the plasma membrane ( Figure 11 ) (Gaullier et al., 1995) , which may also suggest saturating PpIX concentrations around the mitochondrial ferrochelatase. Hence, the present results indicate that the intercept with the ordinate in the double-reciprocal plot can be used to estimate ferrochelatase activity in cells. However, it should be emphasised that the values obtained by this method may differ from the maximum ferrochelatase activity, since availability to iron may be rate limiting even in the absence of iron chelators. Furthermore, 5-ALA-and DEFinduced changes in the intracellular concentrations of modulators of ferrochelatase activity may influence the estimated activities. For example, haemin, the oxidised form of haem, is known to inhibit ferrochelatase activity (Rossi et al., 1990) . It cannot be excluded that DEF may be an inducer of other enzymes in the pathway leading to a haem formation (Sassa and Bernstein, 1977) .
There are several examples from the literature suggesting that the ferrochelatase activity is reduced in neoplastically transformed tumours compared with their normal counterparts (Rebeiz et al., 1992; Dailey and Smith, 1984; van Hillegersberg et al., 1992) . The present results indicate that in WiDr cells there is a 3-fold higher capacity for formation of PpIX than the capacity for incorporation of ferrous iron into PpIX (Figure 9 ). On the other hand, in V79 cells the same ratio is only 1.5: 1. This difference between the two cell lines may be owing to the difference in origin of these cell lines. V79 (Orenstein et al., 1994) . As seen in the present study, the largest benefit of co-treatment with iron chelators is found at low concentrations of 5-ALA (Figures 3 and 5) .
The iron chelator-induced accumulation of PpIX was dependent upon the cell line and the concentration of 5-ALA ( Figure 9 ). The highest effect was observed at the lowest concentration of 5-ALA, and the accumulation could be increased to a higher extent in V79 cells than in WiDr cells. At low concentrations of 5-ALA (<0.025 mM) virtually no PpIX is accumulated in V79 cells. At these low concentrations of 5-ALA ferrochelatase is most likely able to convert all PpIX formed into haem. This is supported by the nearly linear relationship between PpIX accumulation and 5-ALA concentration when the ferrochelatase activity is inhibited by DEF treatment (Figure 6 ).
The iron chelators were also found to enhance the sensitivity of the cells to photoinactivation (Figure 12 ). The studies of PpIX accumulation in cells indicated that iron chelators should be more efficient in increasing the sensitivity of the cells to photoinactivation at low than at high concentrations of 5-ALA. Furthermore, DEF should be expected to be more efficient than EDTA in increasing the sensitivity of the cells to photoinactivation. This was indeed found to be the case for both V79 and WiDr cells ( Figure  12 ). The enhancement was found to be strictly dependent on the amount of PpIX in the cells (data not shown), indicating that the iron chelators do not change the intracellular localisation of PpIX or in other ways change the quantum yield for photoinactivation of the accumulated porphyrins. The fluorescence micrography studies confirmed that no major changes in intracellular localisation of PpIX was induced by the modulators (Figure 11 ). HPLC analysis showed that only PpIX was accumulated in the presence or absence of iron chelators in 5-ALA-treated cells (Figure 10 , 1992) . This is not due to a direct effect of DDC, but rather to the accumulation of N-methyl protoporhyrin IX in hepatocytes by transfer of methyl groups from DDC to PpIX (Ortiz de Montellano et al., 1981) . N-methyl protoporphvrin IX is a potent inhibitor of ferrochelatase (Kimmett et al.. 1992 ). The present results indicate that the transfer of the methyl group from DDC to PpIX does not occur in non-hepatic cells. In contrast. it was found that the accumulation of PpIX was reduced by DDC treatment of cells exposed to 5-ALA (Figures 2-5 ). This inhibition may be cell line dependent (Schoenfeld et al.. 1994 ). Since no porphyrins other than PpIX were found in 5-ALA-and DDC-treated cells (Figure 10 ), DDC is likely to interact at a step in the haem biosynthetic pathway before the formation of uroporphyrin or with the uptake of 5-ALA into the cells.
